# Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

> **NCT03030430** · PHASE1 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 128 (actual)

## Conditions studied

- NSCLC

## Interventions

- **BIOLOGICAL:** BAT1706 injection
- **BIOLOGICAL:** EU-sourced Avastin
- **BIOLOGICAL:** US-sourced Avastin

## Key facts

- **NCT ID:** NCT03030430
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-15
- **Primary completion:** 2017-05-16
- **Final completion:** 2017-06-28
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03030430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03030430, "Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03030430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*